ALLERGIC HYPERSENSITIVITY TO THE 23-VALENT PNEUMOCOCCAL VACCINE: A CASE REPORT

被引:0
|
作者
McCormick, T.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A68 / A68
页数:1
相关论文
共 50 条
  • [31] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Benin, A
    O'Brien, K
    Watt, J
    Reid, R
    Zell, ER
    Katz, S
    Donaldson, C
    Parkinson, A
    Schuchat, A
    Santosham, M
    Whitney, CG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1148 - 1148
  • [32] SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [33] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
    Shiramoto, Masanari
    Hanada, Ryuzo
    Juergens, Christine
    Shoji, Yasuko
    Yoshida, Mizuki
    Ballan, Barry
    Cooper, David
    Gruber, William C.
    Scott, Daniel A.
    Schmoele-Thoma, Beate
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (09) : 2198 - 2206
  • [34] SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN RHEUMATOID ARTHRITIS PATIENTS (PRELIMINARY RESULTS)
    Naumtseva, M. S.
    Belov, B. S.
    Tarasova, G. M.
    Karateev, D. E.
    Luchikina, E.
    Muravyev, Y.
    Alexandrova, E.
    Novikov, A.
    Nasonova, V. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 916 - 916
  • [35] Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
    Masuda, Toshihiro
    Akamatsu, Taisuke
    Nakatani, Eiji
    Tamura, Kanami
    Takahashi, Shingo
    Tanaka, Yuko
    Watanabe, Hirofumi
    Endo, Yoshinari
    Suzuki, Takahito
    Noguchi, Rie
    Saigusa, Mika
    Yamamoto, Akito
    Shishido, Yuichiro
    Akita, Takefumi
    Morita, Satoru
    Asada, Kazuhiro
    Shirai, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] Reports of Injection Site Necrosis After 23-Valent Pneumococcal Vaccine Use
    Day, Brendan
    Thompson, Deborah
    Mba-Jonas, Adamma
    Alimchandani, Meghna
    JAMA INTERNAL MEDICINE, 2023, 183 (09) : 1015 - 1016
  • [37] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine
    Yoon, Dongwon
    Jeon, Ha-Lim
    Kim, Ju Hwan
    Lee, Hyesung
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352597
  • [38] Clinical efficacy of 23-valent pneumococcal capsular polysacharide vaccine in COPD patients
    Muñoz, J
    Alfageme, I
    Reyes, N
    Merino, M
    Perez-Ronchel, J
    Lima, J
    CHEST, 2004, 126 (04) : 837S - 837S
  • [39] Evaluation of appropriateness of vaccination procedures of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in a hospital setting
    Coleman, Paige
    Sears, Matthew
    Vaichys, Sabina
    Nemecek, Branden
    Guarascio, Anthony
    PHARMACOTHERAPY, 2015, 35 (11): : E305 - E305
  • [40] EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS (PRELIMINARY RESULTS)
    Tarasova, G. M.
    Belov, B. S.
    Naumtseva, M. S.
    Soloviev, S. K.
    Aseeva, E. A.
    Klyukvina, N. G.
    Popkova, T. V.
    Alexandrova, E. N.
    Novikov, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 474 - 474